About this trial
Bladder cancer (BLCA), with its diverse histopathological features and varying patient outcomes, poses significant challenges in diagnosis and prognosis. Postoperative survival stratification based on radiomics feature and whole slide image feature may be useful for treatment decisions to improve prognosis. In this research, we aim to develop a deep learning-based prognostic-stratification system for automatic prediction of overall and cancer-specific survival in patients with BLCA.
Eligibility criteria
Qualifiers
patients with bladder cancer who had surgery like radical cystectomy or transurethral resection of bladder tumour (TURBT)
contrast-CT scan less than two weeks before surgery
complete CT image data and clinical data
complete whole slide image data
Disqualifiers
patients with a postoperative diagnosis of non-urothelial carcinoma
poor quality of CT images
incomplete clinical and follow-up data
Trial design
Treatments tested in this trial
- Deep learning system for prognostication prediction in bladder cancer
Treatment groups
Sponsors and collaborators
Mingzhao Xiao
Lead sponsor
First Affiliated Hospital of Chongqing Medical University
Sponsor institution